List of Tables
Table 1. Global Vaccines Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Major Manufacturers of Recombinant Vaccines
Table 3. Major Manufacturers of Viral Vaccines
Table 4. Major Manufacturers of Polysaccharide Vaccines
Table 5. Major Manufacturers of Others
Table 6. Global Vaccines Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 7. Global Vaccines Market Size by Region (US$ Million): 2021 VS 2027
Table 8. Global Vaccines Sales by Region (2016-2021) & (K Pcs)
Table 9. Global Vaccines Sales Forecast by Region (2022-2027) & (K Pcs)
Table 10. Global Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Vaccines Sales by Manufacturer (2016-2021) & (K Pcs)
Table 13. Global Vaccines Sales Share by Manufacturer (2016-2021)
Table 14. Vaccines Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 15. Vaccines Revenue Share by Manufacturer (2016-2021)
Table 16. Key Manufacturers Vaccines Price (2016-2021) & (US$/Pcs)
Table 17. Ranking of Global Top Vaccines Manufacturers by Revenue (US$ Million) in 2020
Table 18. Global Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccines as of 2020)
Table 20. Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Vaccines Product Type
Table 22. Date of International Manufacturers Enter into Vaccines Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. GSK Corporation Information
Table 25. GSK Description and Business Overview
Table 26. GSK Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 27. GSK Vaccines Product
Table 28. GSK Vaccines Revenue (US$ Million) and Market Share by Product
Table 29. GSK Vaccines Revenue (US$ Million) and Market Share by Application
Table 30. GSK Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 31. GSK Vaccines Revenue (US$ Million) and Market Share by Sales Channel
Table 32. GSK Recent Development
Table 33. Sanofi Corporation Information
Table 34. Sanofi Description and Business Overview
Table 35. Sanofi Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 36. Sanofi Vaccines Product
Table 37. Sanofi Vaccines Revenue (US$ Million) and Market Share by Product
Table 38. Sanofi Vaccines Revenue (US$ Million) and Market Share by Application
Table 39. Sanofi Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 40. Sanofi Vaccines Revenue (US$ Million) and Market Share by Sales Channel
Table 41. Sanofi Recent Development
Table 42. Merck Corporation Information
Table 43. Merck Description and Business Overview
Table 44. Merck Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 45. Merck Vaccines Product
Table 46. Merck Vaccines Revenue (US$ Million) and Market Share by Product
Table 47. Merck Vaccines Revenue (US$ Million) and Market Share by Application
Table 48. Merck Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 49. Merck Vaccines Revenue (US$ Million) and Market Share by Sales Channel
Table 50. Merck Recent Development
Table 51. Pfizer Corporation Information
Table 52. Pfizer Description and Business Overview
Table 53. Pfizer Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 54. Pfizer Vaccines Product
Table 55. Pfizer Vaccines Revenue (US$ Million) and Market Share by Product
Table 56. Pfizer Vaccines Revenue (US$ Million) and Market Share by Application
Table 57. Pfizer Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 58. Pfizer Vaccines Revenue (US$ Million) and Market Share by Sales Channel
Table 59. Pfizer Recent Development
Table 60. Novartis(GSK) Corporation Information
Table 61. Novartis(GSK) Description and Business Overview
Table 62. Novartis(GSK) Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 63. Novartis(GSK) Vaccines Product
Table 64. Novartis(GSK) Vaccines Revenue (US$ Million) and Market Share by Product
Table 65. Novartis(GSK) Vaccines Revenue (US$ Million) and Market Share by Application
Table 66. Novartis(GSK) Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 67. Novartis(GSK) Vaccines Revenue (US$ Million) and Market Share by Sales Channel
Table 68. Novartis(GSK) Recent Development
Table 69. CSL Corporation Information
Table 70. CSL Description and Business Overview
Table 71. CSL Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 72. CSL Vaccines Product
Table 73. CSL Vaccines Revenue (US$ Million) and Market Share by Product
Table 74. CSL Vaccines Revenue (US$ Million) and Market Share by Application
Table 75. CSL Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 76. CSL Recent Development
Table 77. MedImmune LLC Corporation Information
Table 78. MedImmune LLC Description and Business Overview
Table 79. MedImmune LLC Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 80. MedImmune LLC Vaccines Product
Table 81. MedImmune LLC Vaccines Revenue (US$ Million) and Market Share by Product
Table 82. MedImmune LLC Vaccines Revenue (US$ Million) and Market Share by Application
Table 83. MedImmune LLC Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 84. MedImmune LLC Recent Development
Table 85. J&J(Crucell) Corporation Information
Table 86. J&J(Crucell) Description and Business Overview
Table 87. J&J(Crucell) Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 88. J&J(Crucell) Vaccines Product
Table 89. J&J(Crucell) Vaccines Revenue (US$ Million) and Market Share by Product
Table 90. J&J(Crucell) Vaccines Revenue (US$ Million) and Market Share by Application
Table 91. J&J(Crucell) Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 92. J&J(Crucell) Recent Development
Table 93. China National Biotec Corporation Information
Table 94. China National Biotec Description and Business Overview
Table 95. China National Biotec Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 96. China National Biotec Vaccines Product
Table 97. China National Biotec Vaccines Revenue (US$ Million) and Market Share by Product
Table 98. China National Biotec Vaccines Revenue (US$ Million) and Market Share by Application
Table 99. China National Biotec Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 100. China National Biotec Recent Development
Table 101. Tiantan Corporation Information
Table 102. Tiantan Description and Business Overview
Table 103. Tiantan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 104. Tiantan Vaccines Product
Table 105. Tiantan Vaccines Revenue (US$ Million) and Market Share by Product
Table 106. Tiantan Vaccines Revenue (US$ Million) and Market Share by Application
Table 107. Tiantan Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 108. Tiantan Recent Development
Table 109. Hualan Corporation Information
Table 110. Hualan Description and Business Overview
Table 111. Hualan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 112. Hualan Vaccines Product
Table 113. Hualan Vaccines Revenue (US$ Million) and Market Share by Product
Table 114. Hualan Vaccines Revenue (US$ Million) and Market Share by Application
Table 115. Hualan Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 116. Hualan Recent Development
Table 117. Kangtai Corporation Information
Table 118. Kangtai Description and Business Overview
Table 119. Kangtai Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 120. Kangtai Vaccines Product
Table 121. Kangtai Vaccines Revenue (US$ Million) and Market Share by Product
Table 122. Kangtai Vaccines Revenue (US$ Million) and Market Share by Application
Table 123. Kangtai Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 124. Kangtai Recent Development
Table 125. Hissen Corporation Information
Table 126. Hissen Description and Business Overview
Table 127. Hissen Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 128. Hissen Vaccines Product
Table 129. Hissen Vaccines Revenue (US$ Million) and Market Share by Product
Table 130. Hissen Vaccines Revenue (US$ Million) and Market Share by Application
Table 131. Hissen Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 132. Hissen Recent Development
Table 133. Jintan Corporation Information
Table 134. Jintan Description and Business Overview
Table 135. Jintan Vaccines Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2016-2021)
Table 136. Jintan Vaccines Product
Table 137. Jintan Vaccines Revenue (US$ Million) and Market Share by Product
Table 138. Jintan Vaccines Revenue (US$ Million) and Market Share by Application
Table 139. Jintan Vaccines Revenue (US$ Million) and Market Share by Geographic Area
Table 140. Jintan Recent Development
Table 141. Global Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 142. Global Vaccines Sales Forecast by Type (2022-2027) & (K Pcs)
Table 143. Global Vaccines Revenue by Type (2016-2021) & (US$ Million)
Table 144. Global Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 145. Global Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 146. Global Vaccines Sales Forecast by Application (2022-2027) & (K Pcs)
Table 147. Global Vaccines Revenue by Application (2016-2021) & (US$ Million)
Table 148. Global Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 149. North America Vaccines Sales by Country (2016-2021) & (K Pcs)
Table 150. North America Vaccines Sales by Country (2022-2027) & (K Pcs)
Table 151. North America Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 152. North America Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 153. North America Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 154. North America Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 155. Asia-Pacific Vaccines Sales by Region (2016-2021) & (K Pcs)
Table 156. Asia-Pacific Vaccines Sales by Region (2022-2027) & (K Pcs)
Table 157. Asia-Pacific Vaccines Revenue by Region (2016-2027) & (US$ Million)
Table 158. Asia-Pacific Vaccines Revenue by Region (2022-2027) & (US$ Million)
Table 159. Asia-Pacific Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 160. Asia-Pacific Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 161. Europe Vaccines Sales by Country (2016-2021) & (K Pcs)
Table 162. Europe Vaccines Sales by Country (2022-2027) & (K Pcs)
Table 163. Europe Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 164. Europe Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 165. Europe Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 166. Europe Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 167. Latin America Vaccines Sales by Country (2016-2021) & (K Pcs)
Table 168. Latin America Vaccines Sales by Country (2022-2027) & (K Pcs)
Table 169. Latin America Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 170. Latin America Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 171. Latin America Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 172. Latin America Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 173. Middle East and Africa Vaccines Sales by Country (2016-2021) & (K Pcs)
Table 174. Middle East and Africa Vaccines Sales by Country (2022-2027) & (K Pcs)
Table 175. Middle East and Africa Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 176. Middle East and Africa Vaccines Revenue by Country (2022-2027) & (US$ Million)
Table 177. Middle East and Africa Vaccines Sales by Type (2016-2021) & (K Pcs)
Table 178. Middle East and Africa Vaccines Sales by Application (2016-2021) & (K Pcs)
Table 179. Vaccines Key Raw Materials, Industry Status and Trend
Table 180. Vaccines Key Raw Materials and Upstream Suppliers
Table 181. Vaccines Clients Status and Trend
Table 182. Vaccines Typical Clients
Table 183. Vaccines Distributors
Table 184. Key Drivers: Impact Analysis (2022-2027)
Table 185. Vaccines Market Drivers
Table 186. Vaccines Market Opportunities
Table 187. Vaccines Market Challenges
Table 188. Vaccines Market Restraints
Table 189. Vaccines Porter’s Five Forces Analysis
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccines Product Picture
Figure 2. Global Vaccines Sales Market Share by Type in 2021 & 2027
Figure 3. Recombinant Vaccines Product Picture
Figure 4. Viral Vaccines Product Picture
Figure 5. Polysaccharide Vaccines Product Picture
Figure 6. Others Product Picture
Figure 7. Global Vaccines Sales Market Share by Application in 2021 & 2027
Figure 8. Rabies vaccine Examples
Figure 9. Influenza vaccine Examples
Figure 10. HPV vaccine Examples
Figure 11. Hepatitis B Examples
Figure 12. Hepatitis A Examples
Figure 13. Leprosy vaccine Examples
Figure 14. Polio vaccine Examples
Figure 15. JE vaccine Examples
Figure 16. Others Examples
Figure 17. Vaccines Report Years Considered
Figure 18. Global Vaccines Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Vaccines Market Size 2016-2027 (US$ Million)
Figure 20. Global Vaccines Sales 2016-2027 (K Units)
Figure 21. Global Vaccines Market Size Market Share by Region: 2021 Versus 2027
Figure 22. Global Vaccines Sales Market Share Forecast by Region (2016-2027)
Figure 23. Global Vaccines Revenue Market Share by Region (2016-2027)
Figure 24. Global Vaccines Sales Share by Manufacturer in 2020
Figure 25. Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Vaccines Sales Market Share Forecast by Type (2016-2027)
Figure 27. Global Vaccines Revenue Market Share Forecast by Type (2016-2027)
Figure 28. Vaccines Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Figure 29. Global Vaccines Sales Market Share Forecast by Application (2016-2027)
Figure 30. Global Vaccines Revenue Market Share Forecast by Application (2016-2027)
Figure 31. Vaccines Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Figure 32. North America Vaccines Revenue 2016-2027 (US$ Million)
Figure 33. North America Vaccines Sales Market Share by Type (2016-2021)
Figure 34. North America Vaccines Sales Market Share by Application (2016-2021)
Figure 35. Asia-Pacific Vaccines Revenue 2016-2027 (US$ Million)
Figure 36. Asia-Pacific Vaccines Sales Market Share by Region (2016-2027)
Figure 37. Asia-Pacific Vaccines Revenue Market Share by Region (2016-2027)
Figure 38. Asia-Pacific Vaccines Sales Market Share by Type (2016-2021)
Figure 39. Asia-Pacific Vaccines Sales Market Share by Application (2016-2021)
Figure 40. Europe Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
Figure 41. Europe Vaccines Sales Market Share by Country (2016-2027)
Figure 42. Europe Vaccines Revenue Market Share by Country (2016-2027)
Figure 43. Europe Vaccines Sales Market Share by Type (2016-2021)
Figure 44. Europe Vaccines Sales Market Share by Application (2016-2021)
Figure 45. Latin America Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
Figure 46. Latin America Vaccines Sales Market Share by Country (2016-2027)
Figure 47. Latin America Vaccines Revenue Market Share by Country (2016-2021)
Figure 48. Latin America Vaccines Sales Market Share by Type (2016-2021)
Figure 49. Latin America Vaccines Sales Market Share by Application (2016-2021)
Figure 50. Middle East and Africa Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
Figure 51. Middle East and Africa Vaccines Sales Market Share by Country (2016-2027)
Figure 52. Middle East and Africa Vaccines Revenue Market Share by Country (2016-2027)
Figure 53. Middle East and Africa Vaccines Sales Market Share by Type (2016-2021)
Figure 54. Middle East and Africa Vaccines Sales Market Share by Application (2016-2021)
Figure 55. Vaccines Supply Chain (Upstream and Downstream Market)
Figure 56. Global Production Market Share of Vaccines Raw Materials by Region in 2020
Figure 57. Vaccines Distribution Channels
Figure 58. Global Vaccines Percentage 2016-2027: Indirect Sales VS Direct Sales
Figure 59. Global Vaccines Percentage 2016-2027: Online Sales VS Offline Sales
Figure 60. Porter's Five Forces Analysis
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed